

Venclexta has serious drug interactions with common medications, supplements, and foods. Learn what to avoid and what to tell your doctor.
Venclexta (Venetoclax) is an effective treatment for blood cancers like CLL, SLL, and AML. But it has some of the most significant drug interactions of any cancer medication on the market. Certain common prescriptions, over-the-counter products, supplements, and even foods can dangerously change how Venclexta works in your body.
This isn't a scare tactic — it's information that can keep you safe. Understanding these interactions is just as important as taking the medication itself.
To understand why Venclexta interacts with so many things, you need to know about an enzyme called CYP3A. This enzyme lives in your liver and is responsible for breaking down Venclexta (and many other drugs) in your body.
Here's the key concept:
Venclexta also interacts with a transporter protein called P-glycoprotein (P-gp), which affects how the drug is absorbed and distributed in your body.
These are the most dangerous interactions. During the Venclexta dose ramp-up phase, these drugs are contraindicated (should not be used at all). After ramp-up, your doctor must reduce your Venclexta dose by at least 75% if you need one of these:
Why this matters: These drugs can increase Venclexta blood levels by 6-8 times, dramatically raising the risk of TLS and other serious side effects.
These medications require at least a 50% reduction in your Venclexta dose:
If you're prescribed any antibiotic or antifungal while on Venclexta, always remind the prescribing doctor that you take Venclexta — even if it seems unrelated to your cancer treatment.
These drugs significantly reduce Venclexta's effectiveness and should not be used during treatment:
Why this matters: Rifampin, for example, can reduce Venclexta levels by up to 70%, potentially rendering your cancer treatment ineffective.
Venclexta doesn't just get affected by other drugs — it can also change how other medications work in your body:
Don't assume that "natural" means safe with Venclexta. Several common supplements and OTC products can interact:
The safest approach: bring a complete list of everything you take — prescription drugs, over-the-counter medications, vitamins, supplements, and herbal products — to every oncology appointment.
Yes, even some foods interact with Venclexta. These are the ones to know about:
Venclexta should be taken with a meal every time. Food increases absorption of the medication, making it more effective. This isn't optional — skipping food can reduce how much Venclexta your body absorbs and may affect treatment outcomes.
Before starting Venclexta — and at every follow-up visit — make sure your healthcare team knows about:
Consider carrying a card in your wallet that lists your medications, including Venclexta, so any healthcare provider who treats you in an emergency will know what you're taking.
Venclexta's drug interactions are serious but manageable — as long as everyone on your healthcare team is informed. The biggest risks come from antifungals, certain antibiotics, seizure medications, and even grapefruit. The solution is simple: communicate, communicate, communicate.
Never start, stop, or change any medication — including supplements — without talking to your oncologist first. And make sure every doctor, dentist, or pharmacist you interact with knows you're taking Venclexta.
Want to learn more about Venclexta? Read our guides on what Venclexta is and how it's used, side effects to watch for, or visit Medfinder to find pharmacies and providers near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.